Literature DB >> 14670612

Alterations of pRb1-cyclin D1-cdk4/6-p16(INK4A) pathway in endometrial carcinogenesis.

Andrzej Semczuk1, Jerzy Andrzej Jakowicki.   

Abstract

The retinoblastoma protein pathway (pRb1-cyclin D1-cdk4/6-p16(INK4A)) participates in the regulation of the cellular processes at the transition of G1/S phases of the cell-cycle. Derailments of this pathway, caused either by lack of pRb1 or p16(INK4A) expression or overexpression of cyclin D1 and/or cdk4/6, are implicated in the deregulation of the cell-cycle machinery, resulting in uncontrolled cell proliferation, tumor heterogeneity, invasion and metastasis. Several studies conducted so far have assessed the deregulation of the pRb1-pathway components in various human tumors and cell-lines, provided these pathway alterations play an obligatory role in tumorigenesis. This review briefly summarizes the current information on the pRb1-cyclin D1-cdk4/6-p16(INK4A) alterations in sporadic uterine cancer, placing emphasis on the influence on the dualistic model of endometrial carcinogenesis.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14670612     DOI: 10.1016/j.canlet.2003.09.012

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  21 in total

Review 1.  Chronic hepatitis B in hepatocarcinogenesis.

Authors:  N H Park; I H Song; Y-H Chung
Journal:  Postgrad Med J       Date:  2006-08       Impact factor: 2.401

2.  Molecular Pathogenesis of Hepatitis-B-virus-associated Hepatocellular Carcinoma.

Authors:  Neung Hwa Park; Il Han Song; Young-Hwa Chung
Journal:  Gut Liver       Date:  2007-12-31       Impact factor: 4.519

3.  A cascade of modules of a network defines cancer progression.

Authors:  Sam Thiagalingam
Journal:  Cancer Res       Date:  2006-08-01       Impact factor: 12.701

4.  PI3K/Akt/JNK/c-Jun signaling pathway is a mediator for arsenite-induced cyclin D1 expression and cell growth in human bronchial epithelial cells.

Authors:  Jin Ding; Beifang Ning; Yi Huang; Dongyun Zhang; Jingxia Li; Chang-Yan Chen; Chuanshu Huang
Journal:  Curr Cancer Drug Targets       Date:  2009-06       Impact factor: 3.428

Review 5.  Aberrant cell cycle regulation in cervical carcinoma.

Authors:  Young Tae Kim; Min Zhao
Journal:  Yonsei Med J       Date:  2005-10-31       Impact factor: 2.759

6.  Gankyrin facilitates follicle-stimulating hormone-driven ovarian cancer cell proliferation through the PI3K/AKT/HIF-1α/cyclin D1 pathway.

Authors:  J Chen; M Bai; C Ning; B Xie; J Zhang; H Liao; J Xiong; X Tao; D Yan; X Xi; X Chen; Y Yu; R C Bast; Z Zhang; Y Feng; W Zheng
Journal:  Oncogene       Date:  2015-09-14       Impact factor: 9.867

7.  Novel germline CDK4 mutations in patients with head and neck cancer.

Authors:  Maimoona Sabir; Ruqia Mehmood Baig; Ishrat Mahjabeen; Mahmood Akhtar Kayani
Journal:  Hered Cancer Clin Pract       Date:  2012-08-29       Impact factor: 2.857

8.  Epigenetic alterations in preneoplastic and neoplastic lesions of the cervix.

Authors:  Kathleen P Saavedra; Priscilla M Brebi; Juan Carlos S Roa
Journal:  Clin Epigenetics       Date:  2012-08-31       Impact factor: 6.551

9.  Constructing the HBV-human protein interaction network to understand the relationship between HBV and hepatocellular carcinoma.

Authors:  Zhong-Jun Wu; Yu Zhu; De-Rong Huang; Zhi-Qiang Wang
Journal:  J Exp Clin Cancer Res       Date:  2010-11-16

10.  pRb2/p130 protein expression and RBL2 mutation analysis in Burkitt lymphoma from Uganda.

Authors:  Sam Kalungi; Solrun J Steine; Henry Wabinga; Leif Bostad; Anders Molven
Journal:  BMC Clin Pathol       Date:  2009-08-19
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.